Today: 23 June 2026
Browse Category

Stock Market 15 December 2025

U.S. index ETFs showed little movement in after-hours trading, with blue-chip stocks slightly up and growth stocks weaker, continuing the regular session’s trend. Amazon shares dropped 4.75% as investors questioned the payoff timeline for the tech industry’s heavy AI spending. Keel Infrastructure rose 5.9% to a new 52-week high, driven by investor interest in its power assets for potential AI data center leasing. Nokia shares climbed in both Helsinki and the U.S. after expanding its AI network-software partnership with Google Cloud. Infleqtion gained about 5% following a White House policy boost for quantum technologies, though risks include ongoing losses and unproven hardware. Nexentis Technologies more than doubled after an AI drug-discovery update, with heavy trading throughout the session. Grab fell 2.24% and is down 30% this year despite higher revenue and profit, as investors weigh its buyback and AI initiatives against concerns about competition and growth. Tesla shares rose 1.14% as focus remained on its robotaxi strategy and potential closer ties among Elon Musk’s companies. Marvell Technology fell 0.9% in its S&P 500 debut but remains up over 260% this year due to AI infrastructure demand, with investors balancing index-fund buying and high valuations. Apple slipped 0.3% but outperformed most large tech peers. Nvidia fell 0.97%, with large tech names dragging the Nasdaq down 1.3%. SpaceX shares dropped 16.43% amid its first bond sale, though the stock remains above its IPO price. Chipotle fell 6%, outpacing the broader restaurant group. Snap remains 19% below its June 15 close, with investor focus on capital discipline. Joby Aviation declined 1.4%, with lawsuits and index changes in focus. Coherent neared a 52-week high, with attention on U.S. indium phosphide capacity amid China’s stricter controls. UiPath fell 1.2% ahead of its annual meeting, with investors watching recurring-contract growth. The S&P 500 lost 0.48% and the Nasdaq 1.41%, as losses in Alphabet and other big tech stocks outweighed sector gains elsewhere. The Dow gained 0.28%, led by Caterpillar and Visa, while Alphabet’s decline weighed on tech. Ford was flat as Canadian contract talks began.
Broadcom Inc. Stock (AVGO) Today: Why Shares Are Volatile After Earnings, AI Backlog Updates, and Wall Street Forecasts (Dec. 15, 2025)

Broadcom Inc. Stock (AVGO) Today: Why Shares Are Volatile After Earnings, AI Backlog Updates, and Wall Street Forecasts (Dec. 15, 2025)

Broadcom shares fell sharply to $359.93 Monday after last week’s earnings, despite reporting Q4 revenue of $18.015 billion, up 28% year over year. Investors reacted to management’s warning that gross margins will dip as AI revenue grows. The company disclosed a $73 billion AI product backlog, but concerns over profitability pressured the stock. Broader tech markets also declined.
Cathie Wood Sells $40M in Tesla, Keeps Cutting Iridium, and Adds Nurix: What ARK Invest’s Latest Trades Signal on Dec. 15, 2025

Cathie Wood Sells $40M in Tesla, Keeps Cutting Iridium, and Adds Nurix: What ARK Invest’s Latest Trades Signal on Dec. 15, 2025

ARK Invest sold nearly 88,000 Tesla shares worth about $39.3 million across its ARKK and ARKW funds on December 12. The firm also trimmed positions in Iridium Communications and added to biotech firm Nurix Therapeutics, while increasing stakes in Robinhood and Block. The moves come as markets remain volatile after a tech-led pullback and ahead of major central bank decisions.
Waterbury Water Main Break Update (Dec. 15, 2025): Thomaston Avenue Repairs Expand, Boil Water Advisory Continues, Schools and Restaurants Remain Disrupted

Waterbury Water Main Break Update (Dec. 15, 2025): Thomaston Avenue Repairs Expand, Boil Water Advisory Continues, Schools and Restaurants Remain Disrupted

A major water main failure on Thomaston Avenue has left about 60% of Waterbury, Connecticut, without service as of Sunday, affecting around 100,000 people. Crews have restored water to some neighborhoods, but a boil advisory remains in place citywide. Officials say repairs will take days, as the damage is worse than expected and requires building new main sections and a bypass. Schools and businesses remain closed, with fire protection relying on tanker trucks.
15 December 2025
Arista Networks Stock (ANET) News Today: What’s Driving the Pullback, the Latest Wall Street Forecasts, and the 2026 Catalysts to Watch (Dec. 15, 2025)

Arista Networks Stock (ANET) News Today: What’s Driving the Pullback, the Latest Wall Street Forecasts, and the 2026 Catalysts to Watch (Dec. 15, 2025)

Arista Networks shares fell 7.17% to $124.76 on Dec. 12, trading on 8.4 million shares, then rebounded about 1% in early pre-market trading Dec. 15. The company announced its new VESPA technology on Dec. 10, targeting large-scale campus wireless mobility for over 500,000 clients. Broader AI sector volatility has influenced recent stock moves.
Nebius Group N.V. (NBIS) Stock: Latest News, Analyst Targets, and 2026 Outlook as AI Infrastructure Demand Collides With Heavy Capex (Dec. 15, 2025)

Nebius Group N.V. (NBIS) Stock: Latest News, Analyst Targets, and 2026 Outlook as AI Infrastructure Demand Collides With Heavy Capex (Dec. 15, 2025)

Nebius Group N.V. shares closed at $87.69 on Dec. 12 after a 6.99% drop, following heavy trading and sharp swings in recent sessions. The selloff comes despite major contracts with Microsoft and Meta and rapid revenue growth, as investors weigh high spending and financing risks. Pre-market trading on Dec. 15 showed a slight rebound. Nebius, formerly Yandex N.V., is Europe’s largest neocloud firm, specializing in GPU-heavy AI infrastructure.
15 December 2025
Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma shares fell about 8% to $0.095 on December 15, 2025, as the company’s stock transferred from the Nasdaq Global Select Market to the Nasdaq Capital Market. Aspire faces Nasdaq deadlines to regain compliance with minimum bid price and equity rules by early 2026. The company is also advancing an FDA regulatory milestone for its sublingual aspirin program.
15 December 2025
Opendoor Technologies (OPEN) Stock Today: Latest News, Warrant Dividend Impact, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Opendoor Technologies (OPEN) Stock Today: Latest News, Warrant Dividend Impact, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Opendoor shares fell nearly 7% to $6.56 at Monday’s open, continuing a year of sharp swings. The company is undergoing a major shift under new CEO Kaz Nejatian, with a focus on AI and software. A special dividend of tradable warrants and skepticism from analysts have added to volatility. Market cap stands at about $6.3 billion.
15 December 2025
Equinox Gold Corp Stock (EQX) in Focus After $1.015 Billion Brazil Mine Sale to CMOC: Latest News, Forecasts, and Key Levels to Watch (Dec. 15, 2025)

Equinox Gold Corp Stock (EQX) in Focus After $1.015 Billion Brazil Mine Sale to CMOC: Latest News, Forecasts, and Key Levels to Watch (Dec. 15, 2025)

Equinox Gold Corp agreed to sell its Brazil operations to a CMOC Group subsidiary for $1.015 billion, including $900 million upfront and up to $115 million contingent on production. Shares traded near $14.70 on Monday after the news. The deal is expected to close in Q1 2026, pending regulatory approvals in Brazil and China. Equinox plans to focus on North American assets.
ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow is in advanced talks to acquire cybersecurity firm Armis for up to $7 billion, according to Reuters. Shares traded near $865 early Dec. 15, down modestly and about 28% below the 52-week high. A 5-for-1 stock split is set for later this week. ServiceNow recently announced plans to buy identity security company Veza, pending regulatory approval.
15 December 2025
Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

Applied Digital shares closed at $27.86 on December 15, down 9.4% in one session after a strong multi-month rally. The company, now valued near $7–8 billion, has shifted focus from crypto to AI data centers, highlighted by two 15-year CoreWeave leases worth $7 billion. Investors cite volatility and risks tied to capital needs and tenant concentration.
15 December 2025
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health shares traded near $16.63 on December 15, 2025, as the ACA open enrollment deadline coincided with new analyst coverage and policy debate in Washington. Congress is weighing the fate of enhanced ACA premium tax credits set to expire at the end of 2025. KFF projects average subsidized premiums could more than double in 2026 if subsidies lapse. Oscar’s business is heavily exposed to these ACA marketplace shifts.
15 December 2025
Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi shares fell about 4% in Paris on December 15 after the company reported a U.S. regulatory delay for tolebrutinib in non-relapsing secondary progressive MS and a failed Phase 3 trial in primary progressive MS. Sanofi will not seek approval for the latter indication. The FDA decision for nrSPMS is now expected after December 28, with further guidance by end of Q1 2026.
Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba’s U.S.-listed shares traded near $155.68 on Dec. 15, 2025, within a volatile 52-week range of $80.06 to $192.67. The company has committed over $52 billion to AI and cloud infrastructure, raising concerns about rising capital expenditures outpacing revenue. Its Qwen AI app surpassed 10 million downloads in its first week and is now integrated into Quark, reaching over 200 million users in China.
New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy shares traded near $1.26 Monday, down 2.3%, as the company faces a December 15 deadline tied to a forbearance agreement on missed interest payments for its 2029 Notes. The agreement covers holders of over 70% of the notes and could trigger acceleration of debt if not extended or restructured. The stock sits near its 52-week low after a year of heavy volatility. Investors remain focused on debt negotiations.
15 December 2025
GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace shares rose about 4% to $299.81, following Citigroup’s initiation of coverage with a Buy rating and $386 target. The company also secured orders to supply LM2500 engines for two U.S. Navy destroyers. Meanwhile, the FAA issued a new airworthiness directive for certain CFM LEAP-1A engines after reports of blade cracks.
Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron shares fell 6.7% to $241.14 ahead of its fiscal Q1 2026 earnings report set for Dec. 17. Options markets are pricing in a post-earnings move of about ±10.8%. Wall Street expects revenue near $12.6–$12.8 billion and EPS around $3.84–$3.91, driven by strong AI-related demand and higher memory prices.
Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare shares traded near $0.42 early December 15, 2025, after the FDA granted Fast Track designation to its lead sleep apnea drug IHL-42X on December 3. The company also received a Nasdaq bid-price compliance extension to April 2026 and saw updated research coverage from Stonegate Capital Partners in November. Analyst coverage remains limited.
15 December 2025
ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

The European Medicines Agency’s CHMP issued a positive opinion recommending conditional marketing authorization for ImmunityBio’s Anktiva plus BCG in BCG-unresponsive non-muscle invasive bladder cancer. IBRX shares closed at $2.36 on Dec. 12, up 7.76% on heavy volume, and traded near $2.39 pre-market Dec. 15. The European Commission has not yet given final approval.
China AI Stocks Today (Dec. 15, 2025): A‑Shares and Hong Kong Tech Slide as CPO & AI Chips Cool—What Analysts Forecast Next

China AI Stocks Today (Dec. 15, 2025): A‑Shares and Hong Kong Tech Slide as CPO & AI Chips Cool—What Analysts Forecast Next

China’s AI-linked stocks fell sharply Monday, with computing power hardware and CPO names leading declines as traders cited global AI capex jitters and weaker China macro data. The Shanghai Composite closed down 0.55%, while the STAR Market’s Sci-Tech Innovation 50 dropped 2.22%. Trading value across Shanghai and Shenzhen slid by about CNY 319 billion from the prior session. Consumer and financial shares held up better.
15 December 2025

Stock Market Today

  • Seoul Stocks Rally to Record Above 9,100 on Chip Sector Gains Amid U.S.-Iran Talks
    June 23, 2026, 3:04 AM EDT. Seoul's KOSPI index closed at an all-time high of 9,114.55 driven by strong gains in semiconductor stocks. SK hynix jumped 5.61%, surpassing Samsung Electronics in market cap for the first time, while SK Square surged over 10%. The market received a boost from signs of progress in U.S.-Iran nuclear talks, which ended their first round agreeing on a 60-day roadmap for a deal. Despite the gains, the Korean won weakened against the U.S. dollar, dropping 10 won to 1,537. Bond yields also rose, with three-year Treasury yields up 2.6 basis points. Retail and institutional investors were net buyers, offsetting foreign investor selling.

Latest articles

Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

23 June 2026
Amazon shares plunged 4.75% to $232.79 as investors questioned whether the company’s massive AI and cloud spending will pay off quickly enough, just ahead of Prime Day—a key test of U.S. consumer demand—with Bank of America projecting $21.6 billion in sales for the event and analysts warning that profit quality could disappoint if shoppers focus on lower-margin essentials.
Keel Shares Hit Record—What’s Next for the Stock

Keel Shares Hit Record—What’s Next for the Stock

23 June 2026
Keel Infrastructure Corp. surged 5.9% to a 52-week high as investors bet its power sites can be converted to AI data-center leases, with shares ending at $6.66 on heavy volume; the stock’s rally now hinges on permits, construction, and landing customer contracts, while upcoming Russell 3000 index inclusion and recent $458 million convertible note financing add both opportunity and dilution risk.
Go toTop